Detalhe da pesquisa
1.
Effect of insulin degludec versus insulin glargine U100 on nocturnal glycaemia assessed by plasma glucose profiles in people with type 1 diabetes prone to nocturnal severe hypoglycaemia.
Diabetes Obes Metab
; 25(6): 1557-1565, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36749303
2.
Comparison of treatment with insulin degludec and glargine U100 in patients with type 1 diabetes prone to nocturnal severe hypoglycaemia: The HypoDeg randomized, controlled, open-label, crossover trial.
Diabetes Obes Metab
; 24(2): 257-267, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34643020
3.
The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial): study rationale and design.
BMC Endocr Disord
; 19(1): 78, 2019 Jul 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31337371
4.
The Effect of Insulin Degludec Versus Insulin Glargine U100 on Glucose Metrics Recorded During Continuous Glucose Monitoring in People With Type 1 Diabetes and Recurrent Nocturnal Severe Hypoglycemia.
J Diabetes Sci Technol
; : 19322968231197423, 2023 Sep 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37671755
5.
A prospective randomised cross-over study of the effect of insulin analogues and human insulin on the frequency of severe hypoglycaemia in patients with type 1 diabetes and recurrent hypoglycaemia (the HypoAna trial): study rationale and design.
BMC Endocr Disord
; 12: 10, 2012 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-22727048
6.
Continuous Glucose Monitoring-Recorded Hypoglycemia with Insulin Degludec or Insulin Glargine U100 in People with Type 1 Diabetes Prone to Nocturnal Severe Hypoglycemia.
Diabetes Technol Ther
; 24(9): 643-654, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35467938
7.
Agreement between fasting and postprandial LDL cholesterol measured with 3 methods in patients with type 2 diabetes mellitus.
Clin Chem
; 57(2): 298-308, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20947697
8.
Prediction of carotid intima-media thickness and its relation to cardiovascular events in persons with type 2 diabetes.
J Diabetes Complications
; 34(10): 107681, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32741659
9.
Psychosocial interventions for reducing diabetes distress in vulnerable people with type 2 diabetes mellitus: a systematic review and meta-analysis.
Diabetes Metab Syndr Obes
; 12: 19-33, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30588053
10.
Generalised arterial calcification in normoalbuminuric patients with type 1 diabetes with and without cardiovascular autonomic neuropathy.
Diab Vasc Dis Res
; 16(1): 98-102, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30345796
11.
Left ventricular remodelling and cardiac chamber sizes in long-term, normoalbuminuric type 1 diabetes patients with and without cardiovascular autonomic neuropathy.
J Diabetes Complications
; 33(2): 171-177, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30355473
12.
Cardiac ventricular sizes are reduced in patients with long-term, normoalbuminuric type 1 diabetes compared to the non-diabetic background population.
Diab Vasc Dis Res
; 16(3): 289-296, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30599765
13.
Incidence of bullosis diabeticorum--a controversial cause of chronic foot ulceration.
Int Wound J
; 5(4): 591-6, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19006577
14.
Effect of Insulin Analogs on Frequency of Non-Severe Hypoglycemia in Patients with Type 1 Diabetes Prone to Severe Hypoglycemia: Much Higher Rates Detected by Continuous Glucose Monitoring than by Self-Monitoring of Blood Glucose-The HypoAna Trial.
Diabetes Technol Ther
; 20(3): 247-256, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29565719
15.
Possible early detection of coronary artery calcium progression in type 1 diabetes: A case-control study of normoalbuminuric type 1 diabetes patients and matched controls.
Diabetes Res Clin Pract
; 141: 18-25, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29679631
16.
The influence of diabetes distress on digital interventions for diabetes management in vulnerable people with type 2 diabetes: A qualitative study of patient perspectives.
J Clin Transl Endocrinol
; 9: 41-47, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29067269
17.
The potential for improvement of outcomes by personalized insulin treatment of type 1 diabetes as assessed by analysis of single-patient data from a randomized controlled cross-over insulin trial.
Diabetes Res Clin Pract
; 123: 143-148, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28012403
18.
Using nonfasting lipids--hemodilution or convenience?
Clin Chem
; 57(9): 1336-8; author reply 1338-40, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21719687
19.
Safety and Efficacy of Liraglutide in Patients With Type 2 Diabetes and End-Stage Renal Disease: An Investigator-Initiated, Placebo-Controlled, Double-Blind, Parallel-Group, Randomized Trial.
Diabetes Care
; 39(2): 206-13, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26283739
20.
Short-term cost-effectiveness of insulin detemir and insulin aspart in people with type 1 diabetes who are prone to recurrent severe hypoglycemia.
Curr Med Res Opin
; 32(10): 1719-1725, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27326862